《New Scientist》1982;95(1316):300。由Jerome Rity领导的波士顿科学家小组,对急性淋巴母细胞性白血病(ALL)患者的研究,成功地取得了极有希望的治疗方法。它既不需要相配合的骨髓供者,又可避免用肿瘤抗体治疗或血清治疗产生的严重的副作用(《Lancet》1982;第Ⅱ卷第60页)。 25年前,ALL几乎被认为是不治之症,而 New Scientist 1982; 95 (1316): 300. The Boston Group of Scientists led by Jerome Rity succeeded in promising promising treatments for acute lymphoblastic leukemia (ALL). It does not require matched myeloid donors and avoids the serious side effects of tumor antibody therapy or serum treatment (Lancet 1982; Vol. II, p. 60). 25 years ago, ALL was almost considered an incurable disease